Homogeneous Immunoassay Background Signal Compensation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current homogeneous immunoassays lack sensitivity and accuracy for detecting analytes like symmetrical dimethyl arginine (SDMA) due to background signal interference in biological samples, particularly when SDMA is present at low concentrations.
Innovation Solution
Development of conjugates of SDMA with enzymes, such as glucose-6-phosphate dehydrogenase (G6PDH), and the use of specific antibodies with minimal cross-reactivity, along with a kit and method that includes separate reaction sequences to account for background signals, allowing for precise determination of SDMA in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If homogeneous immunoassays are used for detecting SDMA, then the assay can be performed in solution phase with simple procedure, but the sensitivity and accuracy are insufficient due to background signal interference
Solution Approach 1:
The assay is divided into two separate reaction sequences: a test reaction sequence that measures total signal (specific + background) and a background reaction sequence that measures only background signal. By segmenting the measurement into these two independent sequences, the patent enables subtraction of background signal from total signal to obtain accurate SDMA-specific signal, thereby resolving the contradiction between operational simplicity and measurement precision.
Solution Approach 2:
An enzyme-labeled SDMA conjugate is introduced as an intermediary substance that competes with endogenous SDMA for antibody binding. This intermediary allows the assay to measure SDMA levels indirectly through enzyme activity while enabling separate measurement and subtraction of background signals, thus improving accuracy without complicating the overall assay procedure.
2Device complexity
If conventional immunoassays are used without background compensation, then the assay procedure is simpler, but the detection sensitivity for low concentration SDMA is insufficient
Solution Approach 1:
The background reaction sequence is performed as a preliminary measurement before the final calculation. By measuring and recording the background signal in advance, the patent enables accurate subtraction from the total signal, thereby improving the reliability of low concentration SDMA detection without adding significant procedural complexity.
3Measurement precision
If background signal compensation is implemented through separate reaction sequences, then the measurement accuracy is improved, but the assay time and procedure complexity increase
Solution Approach 1:
The patent combines the test reaction and background reaction into a single multi-well plate format where both reactions occur in parallel. By merging these sequences into a unified assay platform with shared reagents and simultaneous processing, the patent reduces the time penalty associated with background compensation while maintaining measurement accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach enhances the sensitivity and accuracy of SDMA detection by minimizing background interference, enabling reliable quantification of SDMA in biological samples, which is crucial for assessing renal and cardiovascular functions.
Implementation Method 1
the conversion of NAD to NADH
Implementation Method 2
measuring the conversion of NAD to NADH
Implementation Method 3
contacting the sample with an anti-SDMA antibody specific for free SDMA
Data Source
AI summary
Homogeneous immunoassays that allow for compensation of background signals inherent in samples and reagents. The use of homogeneous immunoassays for the detection of the presence or amount of symmetrical Dimethyl Arginine (SDMA) in biological samples. Reagents and kits for conducting the assays.